• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Becton Dickinson

Becton Dickinson

Becton Dickinson & Co BDX 4 Star

Last Price$145.64Day Change (%)0.73%
Open Price$145.24Day Change ($)1.05
Day Range144.91–146.0152-Week Range111.07–149.98

As of Mon 3/30/2015 5:44:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Credits & Debits

    Credits & Debits

  2. Celgene, Kinder Morgan and Actavis Set to Join the S&P 100; Several Constituent Changes Announced for S&P 500, S&P MidCap 400 and S&P SmallCap 600

    Celgene, Kinder Morgan and Actavis Set to Join the S&P 100; Several Constituent Changes Announced for S&P 500, S&P MidCap 400 and S&P SmallCap 600

  3. BD Acquires CRISI Medical Systems

    BD Acquires CRISI Medical Systems

  4. Research and Markets: Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'

    Research and Markets: Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'

  5. Becton Dickinson BDX Q2 2014 Earnings Call Transcript

    Hello, and welcome to BD's Second Fiscal Quarter 2014 Earnings Call. At the request of BD, today's call is being recorded. It will be available for replay through May 8, 2014, on the Investors page of the bd.com website or by phone at 800-585-8967 for domestic calls and area code 404-537-3406 for ...

  6. Best Positioned for Health-Care Reform

    This screen finds companies ready to take advantage when majorĀ provisions of law take effect in 2014.

  7. June/July 2009 Picks

    Four offerings deemed to be right for right now.

  8. Nominees for 2014 Domestic-Stock Fund Manager of the Year

    Five candidates who did more than ride the market's currents.

  9. Nominees for 2014 Domestic-Stock Fund Manager of the Year

    Five candidates who did more than ride the market's currents.

  10. 2 Names to Gain From Industry Trends

    A retailer's attractive pricing and a health-care firm's favorable prospects create solid growth opportunities for Jensen manager Eric Schoenstein.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.